Form 8-K - Current report:
SEC Accession No. 0001104659-21-133645
Filing Date
2021-11-03
Accepted
2021-11-03 16:13:01
Documents
37
Period of Report
2021-11-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2131692d1_8k.htm   iXBRL 8-K 26122
2 EXHIBIT 99.1 tm2131692d1_ex99-1.htm EX-99.1 96341
3 EXHIBIT 99.2 tm2131692d1_ex99-2.htm EX-99.2 34656
7 GRAPHIC tm2131692d1_ex99-1img001.jpg GRAPHIC 16448
8 GRAPHIC tm2131692d1_ex99-2img001.jpg GRAPHIC 285180
9 GRAPHIC tm2131692d1_ex99-2img002.jpg GRAPHIC 403303
10 GRAPHIC tm2131692d1_ex99-2img003.jpg GRAPHIC 241336
11 GRAPHIC tm2131692d1_ex99-2img004.jpg GRAPHIC 300614
12 GRAPHIC tm2131692d1_ex99-2img005.jpg GRAPHIC 210950
13 GRAPHIC tm2131692d1_ex99-2img006.jpg GRAPHIC 219776
14 GRAPHIC tm2131692d1_ex99-2img007.jpg GRAPHIC 295087
15 GRAPHIC tm2131692d1_ex99-2img008.jpg GRAPHIC 223435
16 GRAPHIC tm2131692d1_ex99-2img009.jpg GRAPHIC 151727
17 GRAPHIC tm2131692d1_ex99-2img010.jpg GRAPHIC 212498
18 GRAPHIC tm2131692d1_ex99-2img011.jpg GRAPHIC 175362
19 GRAPHIC tm2131692d1_ex99-2img012.jpg GRAPHIC 174135
20 GRAPHIC tm2131692d1_ex99-2img013.jpg GRAPHIC 206669
21 GRAPHIC tm2131692d1_ex99-2img014.jpg GRAPHIC 180416
22 GRAPHIC tm2131692d1_ex99-2img015.jpg GRAPHIC 313138
23 GRAPHIC tm2131692d1_ex99-2img016.jpg GRAPHIC 272922
24 GRAPHIC tm2131692d1_ex99-2img017.jpg GRAPHIC 226334
25 GRAPHIC tm2131692d1_ex99-2img018.jpg GRAPHIC 205437
26 GRAPHIC tm2131692d1_ex99-2img019.jpg GRAPHIC 252749
27 GRAPHIC tm2131692d1_ex99-2img020.jpg GRAPHIC 475520
28 GRAPHIC tm2131692d1_ex99-2img021.jpg GRAPHIC 130062
29 GRAPHIC tm2131692d1_ex99-2img022.jpg GRAPHIC 291458
  Complete submission text file 0001104659-21-133645.txt   7885555

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tbph-20211103.xsd EX-101.SCH 3195
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tbph-20211103_lab.xml EX-101.LAB 34594
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tbph-20211103_pre.xml EX-101.PRE 22717
30 EXTRACTED XBRL INSTANCE DOCUMENT tm2131692d1_8k_htm.xml XML 3625
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36033 | Film No.: 211375497
SIC: 2834 Pharmaceutical Preparations